Acasă › Supraponderalitate › Missouri
Studii clinice pentru Supraponderalitate în Missouri
34 studii pentru Supraponderalitate caută participanți în Missouri.
Orașe în Missouri
Text oficial al studiului (în engleză)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Studymetrix Research /ID# 282163, City of Saint Peters
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07752979Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity
- Saint Louis University, St Louis
În curs de recrutare
Vârste de la 18 la 35 · Toate sexele · Actualizat 2 oct. 2026 · NCT07853898Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
- Saint Louis University, St Louis
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de la 18 la 35 · Toate sexele · Actualizat 30 sept. 2026 · NCT07849439AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- StudyMetrix Research LLC, City of Saint Peters
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Amicis Centers of Clinical Research, St Louis
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Clinvest Headlands Llc, Springfield
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07794579A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Kansas City
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Washington University School of Medicine, St Louis
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Sundance Clinical Research, St Louis
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington University School of Medicine, St Louis
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Clinical Research Professionals, Chesterfield
- Clinvest Headlands Llc, Springfield
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Clinical Research Professionals, Chesterfield
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, St Louis
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Clayton Sleep Institute - St. Louis - Tesson Ferry Road, St Louis
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- StudyMetrix Research, City of Saint Peters
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
- și încă 1
În curs de recrutareFaza 3
Vârste de la 45 la 99 · Toate sexele · Actualizat 22 sept. 2026 · NCT07037433A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- StudyMetrix Research, City of Saint Peters
- Clinvest Headlands Llc, Springfield
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 22 sept. 2026 · NCT07589608A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, St Louis
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Columbia
- AURORA-2 Clinical Site, St Louis
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Kansas City VA Medical Center, Kansas City
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Clinvest Research LLC, Springfield
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Chesterfield
- ACCOMPLISH-2 Research Site, City of Saint Peters
- ACCOMPLISH-2 Research Site, Hazelwood
- și încă 2
În curs de recrutareFaza 3Voluntari sănătoși bineveniți
Vârste de la 18 la 79 · Toate sexele · Actualizat 11 sept. 2026 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- StudyMetrix Research LLC, City of Saint Peters
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07770841A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- StudyMetrix Research, City of Saint Peters
- Clinvest Headlands Llc, Springfield
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research - Kansas City, Kansas City
În curs de recrutareFaza 3
Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research - Kansas City, Kansas City
În curs de recrutareFaza 3
Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Jefferson City
- Research Site, Kansas City
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 aug. 2026 · NCT07784725AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Clinvest Research, Springfield
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 17 aug. 2026 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Chesterfield
- ACCOMPLISH-1 Research Site, Hazelwood
- ACCOMPLISH-1 Research Site, St Louis
În curs de recrutareFaza 3
Vârste de la 18 la 79 · Toate sexele · Actualizat 10 aug. 2026 · NCT07654361Advancing Biopsychosocial Care Training Initiative
- Washington University School of Medicine, St Louis
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de 5 ani și peste · Toate sexele · Actualizat 10 aug. 2026 · NCT07049861Effects of Grape Consumption on the Immune-Gut Axis in Obesity
- University of Missouri-Columbia, Columbia
În curs de recrutare
Vârste de la 18 la 60 · Toate sexele · Actualizat 31 iul. 2026 · NCT07231484Effect of Ketone Esters on Liver Fat Content and Metabolic Function
- Washington University School of Medicine, St Louis
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
Vârste de la 18 la 40 · Toate sexele · Actualizat 15 iul. 2026 · NCT07097506A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
- MBX Biosciences Investigational Site, Kansas City
În curs de recrutareFaza 1
Vârste de la 18 la 65 · Toate sexele · Actualizat 9 iun. 2026 · NCT07142707Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- Washington University School of Medicine, St Louis
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 12 la 17 · Toate sexele · Actualizat 18 dec. 2025 · NCT05277558Social Determinants and a Diabetes Prevention Program Tailored for African Americans
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 mai 2025 · NCT05301413Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.